Table A1.
More information on authorized/approved vaccines in at least one country as per 15 November 2021.
| No | Vaccine Name | Age Group | Common Side Effect(s) | Main User–Country |
|---|---|---|---|---|
| 1 | ComirnatyTM (BNT162b2) | 5 years of age and older [84] | Pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, and fever | US, UK, South Korea, Singapore, Saudi Arabia, New Zealand, Japan, Israel, Hungary, Germany, France, Canada, Australia |
| 2 | Moderna COVID-19 VaccinemRNA-1273 and mRNA-1273.351 | 18 years of age and older [88] | Pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, swollen lymph nodes in the same arm as the injection, nausea and vomiting, and fever | US, UK, Singapore, France |
| 3 | COVID-19 Vaccine AstraZeneca (AZD1222) | 18 years of age and older [91] | Injection site pain or tenderness, tiredness, headachemuscle pain, fever and chills | UK, South Korea, Saudi Arabia, Phillipines, India, Germany, France, Canada, Brazil, Australia |
| 4 | ConvideciaTM (Ad5-nCoV) | 18 years of age and older [155] | Injection site pain, mild to severe fever (up to grade 3), headache, mild to severe fatigue (up to grade 3), muscle and joint pain, throat pain and cough. | China, Pakistan |
| 5 | Ad26.COV2.S | 18 years of age and older [95] | Arm (pain, redness, swelling), body (tiredness, headache, muscle pain, chills, fever, nausea) | US, South Africa, The Netherlands |
| 6 | BBIBP-CorV | 18 years of age and older [98] | Headaches, fatigue, injection site reactions | China, Hungary, UAE |
| 7 | Inactivated SARS-CoV-2 (vero cell) | 18 years of age and older | Injection site pain, followed by fever, which were mild and self-limiting | China, UAE |
| 8 | CoronaVac | 18 years of age and older [99] | Injection site reactions, fatigue, diarrhea, and muscle pain | China, Brazil, Turkey, Indonesia, Phillipines |
| 9 | Sputnik V | N/A | Headaches, pain at injection site | Russia |
| 10 | EpiVacCorona | N/A | N/A | Turkmenistan, Russia |
| 11 | ZF2001/RBD-Dimer | N/A | Common mild side-effects including injection pain, redness and swelling | China, Uzbekistan |
| 12 | Soberana 2/Pasteur | N/A | Pain and redness at the injection site, general malaise | Iran |
| 13 | Abdala/CIGB-66 | N/A | No serious adverse side effect | Cuba |
| 14 | Medigen | N/A | No vaccine-related serious adverse effects | Taiwan |
| 15 | Covaxin® | 18 years of age and old-er [156] | Fever, headaches, irritability, pain, swelling, or both at the site of injection | India |
| 16 | QazCovid-in® | N/A | No serious side effects | Kazakhstan |
| 17 | Inactivated (Vero Cells) | N/A | N/A | China |
| 18 | COVIran Barekat | N/A | N/A | Iran |
| 19 | CoviVac | N/A | N/A | Russia |
| 20 | NVX-CoV2373 | N/A | N/A | Indonesia, Denmark |
| 21 | ZyCoV-D | N/A | N/A | India |
| 22 | COVAX-19® | N/A | N/A | Iran |
| 23 | Soberana Plus | N/A | N/A | Cuba |